Abstract
pys in children age <1 and <5, respectively.
Conclusions
The incidence of Hib meningitis in children under the age of 5 in Campinas during 1997-98 was similar to that reported in the US, Western Europe, and Israel prior to widespread Hib vaccine use in those regions. This study provides a baseline for later studies to evaluate changes in the etiology and incidence of bacterial meningitis in children after introduction of routine Hib vaccination in Brazil. 
Resumo

Objetivo
Documentar a incidência e a epidemiologia descritiva de meningites bacterianas entre pessoas com idade inferior a 20 anos em uma região geográfica definida do Brasil. O período foi de dois anos, imediatamente anterior à introdução da vacina contra Haemophilus influenzae tipo b (Hib), no Programa Nacional de Imunização do Brasil.
Descritores
INTRODUCTION
Bacterial infections remain an important cause of morbidity and mortality in children despite the availability of highly effective antibiotics. In many countries where vaccination against Haemophilus influenzae type b (Hib) disease is not yet widely adopted, this organism is responsible for a substantial fraction of the cases of meningitis in children under five years of age. 4, 16, 20, 23 In the United States, before the era of Hib vaccines, more than 70% of bacterial meningitis among children less than five years old was attributable to Hib. 19 Published data from the U.S. show that the incidence of Hib meningitis among children under 5 years of age decreased from 25 cases per 10, 5 in 1984, to less than 2.5 cases per 10 5 in 1993 after the introduction of conjugate vaccines since 1988. 21 In Brazil, several studies have been performed over the past ten years evaluating the etiology, treatment, or outcomes of bacterial meningitis in newborns and children. 2, 5, 7, 10, 14, 18 However, only limited information on the etiology, incidence and treatment outcomes of bacterial meningitis in geographically defined regions are available. The present study was conducted to provide an overview of the etiology, incidence rates, antimicrobial use, and outcome of reported bacterial meningitis cases among children in Campinas, SP, Brazil, during a two-year period immediately preceding the implementation of the Hib vaccination as a part of the national immunization program in July 1999. The information may serve as a baseline for further studies to evaluate the effectiveness of the Hib vaccination program.
METHODS
Geography and study population
In 1998, Campinas, in southeast Brazil, had 930,659 residents of which 316,570 were under 20 years of age (50.8% male) and 77,150 were under 5 years of age (51.3% male).*
Epidemiological surveillance
The "Secretaria de Saúde do Município de Campinas" (Campinas Health Department) was in charge of the epidemiological surveillance. There was a mandatory requirement for all cases of meningitis to be reported to the Campinas Health Department. All reports of meningitis arising from hospital inpatients, emergency room patients, death certificates, autopsies, outpatients, and telephone calls were recorded in a standardized meningitis abstract form. Information collected included: demographics, date of onset, previous contact with similar cases, type of contact, clinical manifestations, *Personal communication: Seade (Sistema Estadual de Análises de Dados Estatísticos); http://www.seade.gov.br laboratory data, final diagnosis, criteria used to define diagnosis, hospitalization, prior antimicrobial use, antimicrobial treatment, and outcome. The notifications were regionally computerized and submitted to the coordinating center (CoVISA -Coordenadoria de Vigilância e Saúde, Health and Surveillance Coordinating Center), where the information was centralized into the notification system database (SINAN -Sistema de Informações de Agravos de Notificação).
Data collection
The Campinas Health Department provided a copy of the SINAN database with data on meningitis for this study. Respecting standard ethical procedures, this study reviewed all reported cases of bacterial meningitis reported in Campinas among individuals under 20 years of age, notified from January 1, 1997 to December 31, 1998. All cases whose residence was Campinas, but who were eventually seen by a health professional outside the city were reported by this system, since the complete investigation process and control measures were responsibility of the Campinas Health Department. Cases whose residence was outside Campinas were excluded. Sex, age, date of onset, laboratory data, final diagnosis, criteria used to define diagnosis, hospitalization, prior antimicrobial use, antimicrobial treatment, and outcome were extracted, reviewed and analyzed.
Case definition and diagnostics
The diagnostic criteria for bacterial meningitis included at least one of the following: , neutrophils ≥ 60%, protein ≥ 100 mg/dL and glucose ≤ 50 mg/dL in the presence of clinical manifestations of meningitis.
Statistical analysis
Two years of collected data (1997-1998) were analyzed for this study. Overall incidence and agespecific incidence rates were calculated in cases per 10 5 pys (person-years) according to the Campinas population during the two-year period. Tests of statistical significance were performed using chi-square, Fisher's exact test, t-Test and ANOVA and 95% confidence intervals were computed when applicable.
RESULTS
Epidemiology and etiology
Over the two-year period 274 cases of bacterial meningitis were found. N. meningitidis was the most common cause of bacterial meningitis (19.3%), followed by Hib, (9.5%), Streptococcus pneumoniae (S. pneumoniae) (7.7%), and other etiologic agents (8.0%). No specific organisms were isolated in 152 cases (55.5%). Table 1 shows the diagnostic criteria were used to identify the different organisms. Most of the Hib cases were identified by antigen detection with latex agglutination in the CSF.
Sex and age distribution
One hundred and sixty cases were male (58.4%). 
Other etiologic agents
Other reported etiological agents included: P. aeruginosa (4 cases, age 7 days-5 months), K. pneumoniae (4 cases, age 3-7 months), and 14 cases with a variety of organisms typical of skin contaminants.
Incidence rates
The incidence rate ratio of males to females for (Table 3 ). For Hib, the incidence rates overall and for children <5 were stable. The incidence rate of Hib for children under age one decreased by 62%. The incidence rates for N. meningitidis, S. pneumoniae, other etiologies, and unspecified meningitis increased across nearly all age groups and overall, ranging from an increase of 32% for N. meningitidis to 118% for other etiologies.
Morbidity and mortality
There were 24 deaths among the population studied. The total case fatality rate (CFR) was 8.8%. Seventyfive percent of deaths occurred in children less than five years old and 45.8% occurred in children less than one year old. There were four deaths among the Hib cases (CFR=15.4%, 100% <5 years old, 50% <1 Among the 252 survivors, 16 (5.8%) had sequelae: three among Hib cases (11.5%, 100% under five years old, 33.3% under one year old); five among N. meningitidis cases (9.4%, 100% under five years old, 40% under one year old); three among S. pneumoniae cases (14.3%, 66.7% under one year old); and five among unspecified cases (3.3%, 40% under one year old). Data on sequelae were missing for 84 cases (30.7%). The type of sequelae was not recorded.
Hospitalization
The sum of hospitalization patient-days for all cases was 3,374. The total average length of stay was 12.4 days (SD 9.0, range 1-64). Table 4 shows the average length of stay (ALOS) and ranges of stay for each of the types of meningitis. The difference between these type-specific average lengths of stay was not statistically significant.
Prior antimicrobial use
Eleven cases (4.0%) had documented prior antimi- 
Antimicrobial treatment
Antimicrobial treatment was recorded for 67.5% of the cases, including 88.5% of the Hib cases. Ampicillin plus chloramphenicol was the most widely used antimicrobial treatment. Cephalosporins were the second most widely used antimicrobial treatment for all agents, except S. pneumoniae, for which penicillin was the second most widely used drug (19.0%). Table 5 provides a more detailed listing by etiologic agent and age group of the various combinations of antibiotics used.
DISCUSSION
Hib represented a smaller percent of bacterial meningitis among children in Campinas (9.5%) than in previous studies in Bahia, Brazil (23.0% and 26.0%), 2, 14 and in several studies from different countries with the highest percent of 47.2% and 51.7% in Ecuador 2 and China, respectively. 22, 23 S. pneumoniae was observed as the primary agent in Congo 13 while N. meningitidis was ranked the first agent responsible for bacterial meningitis in this study and in recent reports from Italy (Naples), Spain and Russia. 4, 11, 17 Interpretation of these comparisons is complicated by the varying percentages of cases with unknown etiology. This percentage was higher in the present study (55.5%) than in other populations, including Seville, Spain (14.5%), and Naples, Italy (46.7%). 6, 17 Seasonal peaks were observed for Hib and N. meningitidis in this study, which were consistent with those found in other studies. 11, 12 Sex and age distribution of cases in this study was consistent with other published studies. [11] [12] [13] 19, 22 The incidence rate for Hib meningitis among children under 5 (17 cases per 10 5 pys) in this study is comparable to those found in the U.S., Israel and Western Europe before the use of Hib conjugate vaccines, or in recent reports in unvaccinated populations. 3, 9, 12, 15, 20 Values from Argentina revealed similar incidence rate among children younger than five. 16 A report from Spain (Valencia) revealed an incidence rate of 14 cases per 10 5 for meningitis caused by Hib among unvaccinated children under five years of age. 12 The results of the study suggest that the incidence rates of bacterial meningitis increased from 1997 to 1998. In 1998, the notification system for bacterial meningitis underwent improvement. Thus, more complete notification could help explain the higher rates found for 1998. It could not be determined whether the increase in rates for all agents (except Hib) were due to better reporting, a shift in the overall number of cases (all ages) to the younger age groups (age<20), a true change in the incidence rates, or a combination of these possible explanations.
The clinical course of bacterial meningitis may be complicated by treatment with inadequate dosing of antimicrobials. Symptoms can be temporarily suppressed and delay the diagnosis and provision of effective antibiotic therapy. Thus, poorer outcome may be associated with prior antimicrobial use. In this study the comparison of the outcomes between those with documented prior antimicrobial use versus no prior antimicrobial use was jeopardized by the small number of subjects with documented prior antimicrobial use (4%) and the large amount of under-reporting (50%). While the reported prior antimicrobial use in this study was lower than in Australia, Chile and China, 38%, 41.1% and 100%, 1, 8, 22 the validity of the comparison of outcomes is limited by potential under-reporting of prior antimicrobial use.
The incidence of Hib meningitis in children under 5 years of age in Campinas during the period immediately preceding the national Hib vaccination program is comparable to rates found in the USA, Israel, and Western Europe before the introduction of Hib conjugate vaccines. It will be of interest to see whether the dramatic declines in incidence, which occurred in those regions with widespread vaccination, will also be found in Campinas over the coming decade.
